Device Partnership
Continuous Glucose Monitoring with the World's Most-Used CGM
Abbott's FreeStyle Libre sensors — Libre 3 and Libre 2 — deliver real-time glucose readings every minute with 14-day sensor wear via LibreView cloud integration with CCN Health's clinical platform. Factory calibrated, no fingersticks, no scanning required.
Platform Overview
Glucose data every minute.
FreeStyle Libre 3 provides the highest reading frequency of any CGM — every 1 minute, 1,440 readings per day, delivered to CCN Health's clinical platform via LibreView cloud API.
Platform Integration
The CCN Health platform.
FreeStyle Libre device readings flow into CCN Health's clinical platform for real-time monitoring, alerting, and automated EHR documentation.
FreeStyle Libre
CCN Health Platform
How It Works
From sensor to clinical insight.
FreeStyle Libre CGM data flows through Abbott's LibreView cloud platform to CCN Health via secure API integration — delivering continuous glucose trends without manual patient interaction.
Sensor Measurement
FreeStyle Libre's subcutaneous filament measures interstitial glucose levels continuously, generating a new reading every 1 minute automatically.
Bluetooth Relay
The sensor transmits readings via Bluetooth to the FreeStyle Libre app on the patient's smartphone, which syncs to Abbott's LibreView cloud platform.
LibreView Cloud Integration
CCN Health's platform pulls glucose data from LibreView's cloud API — 1,440 data points per day with trend direction, time-in-range, and ambulatory glucose profile.
Clinical Processing
CCN Health processes glucose trends, calculates time-in-range metrics, generates alerts for hypo/hyperglycemia, and posts data to the patient's EHR.
Clinical Capabilities
Beyond spot-check glucose.
FreeStyle Libre CGM data combined with CCN Health's clinical platform unlocks glucose insights that traditional meters cannot provide.
Time-in-Range Analytics
Calculates the percentage of time glucose stays within target range (70-180 mg/dL). The gold-standard metric for diabetes management beyond HbA1c.
Glucose Pattern Insights
Minute-by-minute data reveals granular glucose patterns — post-meal spikes, dawn phenomenon, overnight trends, and exercise response with higher resolution than 5-minute CGMs.
Real-Time Alerts
Configurable alerts for urgent low, low, high, and signal loss events. CCN Health escalates critical glucose events to care teams automatically.
Ambulatory Glucose Profile
14-day AGP reports standardized by the international diabetes technology community — showing median glucose, variability bands, and time-in-range across the full day.
CMS Compliance
Continuous data transmission satisfies CPT 99454 device transmission day requirements. CGM readings automatically document qualifying RPM interactions.
LibreView Sharing
LibreView enables care teams to access patient glucose data remotely, generate reports, and share insights across providers — integrated directly with CCN Health's platform.
CGM Lineup
FreeStyle Libre sensors in the CCN Health ecosystem.
Abbott's FreeStyle Libre portfolio connects to CCN Health via LibreView cloud API integration — providing continuous glucose data for diabetes RPM programs.
| Device | Connectivity | Data Synced |
|---|---|---|
| FreeStyle Libre 3 | Bluetooth → LibreView cloud | Glucose every 1 min, real-time alerts, 14-day sensor, smallest iCGM sensor, MARD 7.9%, 60-min warm-up, no scanning required |
| FreeStyle Libre 2 | Bluetooth + NFC → LibreView cloud | Glucose every 1 min, optional real-time alerts, 14-day sensor, MARD 9.2%, 60-min warm-up, scan or real-time mode |
Device Gallery
Continuous glucose monitoring lineup.
FreeStyle Libre sensors deliver 1,440 glucose readings per day at 1-minute intervals — factory calibrated with no fingersticks required. LibreView cloud integration with CCN Health for real-time clinical data.
FreeStyle Libre 3
FDA iCGM-cleared continuous glucose monitor delivering real-time glucose readings every minute. The smallest and thinnest iCGM sensor available — 14-day wear, factory calibrated, no scanning required. Bluetooth transmission to smartphone with LibreView cloud sync to CCN Health.
FreeStyle Libre 2
FDA iCGM-cleared CGM with optional real-time glucose alerts. 14-day sensor wear with both scan-based and real-time reading modes. Bluetooth Low Energy connectivity with LibreView cloud integration for remote glucose monitoring.
About Abbott / FreeStyle Libre
The world's most-used continuous glucose monitor.
Abbott (NYSE: ABT) is a global healthcare company with over $40 billion in annual revenue. The FreeStyle Libre system is the world's most-used continuous glucose monitoring platform, with over 5 million users in more than 60 countries. FreeStyle Libre 3 — the smallest and thinnest iCGM sensor available — delivers glucose readings every minute with a MARD of 7.9% and 14-day sensor wear. Abbott's LibreView cloud platform enables seamless data sharing between patients, providers, and clinical platforms like CCN Health. The FreeStyle Libre portfolio is FDA iCGM-cleared and factory calibrated, requiring no fingerstick calibration.